Related Experiment Video
Updated: Apr 15, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Hospital-Onset Bloodstream Infections: Progressive Shift from Methicillin-Resistant Staphylococcus aureus to
Silvia Boni1, Marina Sartini2,3, Filippo Del Puente1
1Department of Infectious Diseases, Galliera Hospital, 16128 Genoa, Italy.
None:
Background: Staphylococcus aureus bloodstream infections cause substantial hospital mortality (20-50%). Surveillance programs primarily focus on methicillin-resistant S. aureus (MRSA) as a quality indicator, while comprehensive data comparing MRSA and methicillin-susceptible S. aureus (MSSA) hospital-onset bacteremia remain limited outside the UK, the USA, and Canada. This study aims to evaluate incidence trends of all hospital-onset S. aureus bloodstream infections (HO-SABSIs, defined as positive blood cultures ≥ 48 h post-admission) from 2013 onwards, comparing MRSA and MSSA incidence patterns and their associated mortality rates in an Italian tertiary-care hospital through surveillance data. Methods: Retrospective cohort study of all HO-SABSIs from January 2013 to December 2023 at a 458-bed Italian tertiary hospital. Primary outcome was incidence density (cases per 1000 patient-days) stratified by methicillin resistance. Standardized Infection Ratios (SIRs) were calculated using 2013-2015 and 2013-2019 as baseline periods. Temporal trends were analyzed using negative binomial regression. Results: Among 414 HO-SABSI cases, 183 (44.2%) were MRSA and 231 (55.8%) MSSA. MRSA incidence decreased significantly (-6.5% annually; IRR 0.935, 95%CI 0.883-0.991; p = 0.023) from 0.198 to 0.111 per 1000 patient-days. MSSA increased non-significantly (+4.9% annually; IRR 1.049, 95%CI 0.999-1.103; p = 0.056) from 0.103 to 0.239, surpassing MRSA after 2016 and peaking during COVID-19 (2021: SIR 2.41, 95%CI 1.33-4.37). MRSA cases had higher mortality than MSSA (40.6% vs. 27.5%; p = 0.005). Conclusions: MSSA has replaced MRSA as the predominant hospital-onset S. aureus bacteremia pathogen since 2016, with sustained elevation during and after the COVID-19 pandemic. Current MRSA-focused surveillance misses the majority of preventable staphylococcal bacteremias. Comprehensive hospital-onset S. aureus surveillance encompassing both phenotypes is essential for accurate epidemiological assessment and infection prevention.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Development of Antibiotic Resistance
Mismatch Repair
Antibiotic Selection

